Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

>> Preview...
Free White Paper

>> Download now...

Asymchem Keeps Building as API Sourcing Reacts to Heparin Scandal

publication date: Jun 6, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Asymchem Laboratories Inc., a privately held CMO/CRO headquartered in North Carolina but with its operations centered in China, has begun construction of a new $34.6 million API manufacturing facility in Jilin province, the company’s seventh facility in China. Meanwhile, the recent heparin scandal is having an effect on the API business in China.  More details...




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners